An update on the treatment of canine atopic dermatitis

Veterinary Journal

Volumn 207, Issue , 2016, Pages 29-37

  Saridomichelakis, Manolis N ^a   Olivry, Thierry ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Atopic dermatitis; Ciclosporin; Dog; Glucocorticoids; Oclacitinib

Indexed keywords

AMITRIPTYLINE; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CETIRIZINE; CYCLOSPORIN; DEXTROMETHORPHAN; DOXEPIN; FATTY ACID; FLUOXETINE; GLUCOCORTICOID; HYDROCORTISONE ACEPONATE; HYDROXYZINE; KETOCONAZOLE; METHYLPREDNISOLONE; MISOPROSTOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OCLACITINIB; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; TACROLIMUS; TEPOXALIN; TRICYCLIC ANTIDEPRESSANT AGENT; DERMATOLOGICAL AGENT; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; DERMATITIS; DIET RESTRICTION; DOG DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENVIRONMENTAL STRESS; EPIDERMIS; FOOD ALLERGY; GENETIC PREDISPOSITION; HELPER CELL; HOUSE DUST ALLERGY; IMMUNOTHERAPY; INFLAMMATORY CELL; MALASSEZIA DERMATITIS; MAST CELL DEGRANULATION; MORNING DOSAGE; NONHUMAN; PROVOCATION TEST; PRURITUS; PYODERMA; REVIEW; SKIN ATROPHY; SKIN DISEASE; SKIN SENSITIZATION; ANIMAL; DOG; DOG DISEASES; VETERINARY;

ANIMALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; GLUCOCORTICOIDS; PYRIMIDINES; SULFONAMIDES;

EID: 84952933993     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2015.09.016     Document Type: Review

References (145)

1. Abba C., Mussa P.P., Vercelli A., Raviri G. Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet. Journal of Animal Physiology and Animal Nutrition 2005, 89:203-207.
2. Beco L., Guaguère E., Lorente Méndez C., Noli C., Nuttall T., Vroom M. Suggested guidelines for using systemic antimicrobials in bacterial skin infections (1): Diagnosis based on clinical presentation, cytology and culture. Veterinary Record 2013, 172:72-78.
3. Beco L., Guaguère E., Lorente Méndez C., Noli C., Nuttall T., Vroom M. Suggested guidelines for using systemic antimicrobials in bacterial skin infections: Part 2 - antimicrobial choice, treatment regimens and compliance. Veterinary Record 2013, 172:156-160.
4. Bensignor E. Evaluation of intermittent topical therapy in the control of recurrent allergic otitis externa in dogs: A randomized, double-blinded, placebo controlled study. Veterinary Dermatology 2008, 19(Suppl. 1):71.
5. Bensignor E., Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: A blinded randomized controlled trial. Veterinary Dermatology 2005, 16:52-60.
6. Bensignor E., Pattyn J., Reme C. Prediction of relapses of recurrent otitis externa in atopic dogs with twice-weekly topical application of hydrocortisone aceponate in the ear canal: A randomized, blinded, controlled study. Veterinary Dermatology 2012, 23(Suppl. 1):92.
7. Bethlehem S., Bexley J., Mueller R.S. Patch testing and allergen-specific serum IgE and IgG antibodies in the diagnosis of canine adverse food reactions. Veterinary Immunology and Immunopathology 2012, 145:582-589.
8. Bexley J., Nuttall T.J., Hammerberg B., Fitzgerald J.R., Halliwell R.E. Serum anti-Staphylococcus pseudintermedius IgE and IgG antibodies in dogs with atopic dermatitis and nonatopic dogs. Veterinary Dermatology 2013, 24:19-24. e5; 6.
9. Bizikova P., Papich M.G., Olivry T. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. Veterinary Dermatology 2008, 19:348-357.
10. Bizikova P., Linder K.E., Paps J., Olivry T. Effect of a novel topical diester glucocorticoid spray on immediate- and late-phase cutaneous allergic reactions in Maltese-beagle atopic dogs: A placebo-controlled study. Veterinary Dermatology 2010, 21:71-80.
11. Blaskovic M., Rosenkrantz W., Neuber A., Sauter-Louis C., Mueller R.S. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis. The Veterinary Journal 2014, 199:39-43.
12. Bond R., Curtis C.F., Hendricks A., Ferguson E.A., Lloyd D.H. Intradermal test reactivity to Malassezia pachydermatis in atopic dogs. Veterinary Record 2002, 150:448-449.
13. Bruet V., Bourdeau P.J., Roussel A., Imparato L., Desfontis J.C. Characterization of pruritus in canine atopic dermatitis, flea bite hypersensitivity and flea infestation and its role in diagnosis. Veterinary Dermatology 2012, 23. 487-e93.
14. Carlotti D.N., Boulet M., Ducret J., Machicote G., Jasmin P., Reme C.A., Albouy M. The use of recombinant omega interferon therapy in canine atopic dermatitis: A double-blind controlled study. Veterinary Dermatology 2009, 20:405-411.
15. Chen T.A., Halliwell R.E., Pemberton A.D., Hill P.B. Identification of major allergens of Malassezia pachydermatis in dogs with atopic dermatitis and Malassezia overgrowth. Veterinary Dermatology 2002, 13:141-150.
16. Collard W.T., Hummel B.D., Fielder A.F., King V.L., Boucher J.F., Mullins M.A., Malpas P.B., Stegemann M.R. The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog. Journal of Veterinary Pharmacology and Therapeutics 2014, 37:279-285.
17. Colombo S., Hill P.B., Shaw D.J., Thoday K.L. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: A prospective, double-blinded, clinical study. Veterinary Dermatology 2005, 16:162-170.
18. Colombo S., Hill P.B., Shaw D.J., Thoday K.L. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy. Veterinary Record 2007, 160:861-864.
19. Cornegliani L., Vercelli A., Sala E., Marsella R. Transepidermal water loss in healthy and atopic dogs, treated and untreated: A comparative preliminary study. Veterinary Dermatology 2012, 23:41-44. e9; 10.
20. Cosgrove S.B., Wren J.A., Cleaver D.M., Martin D.D., Walsh K.F., Harfst J.A., Follis S.L., King V.L., Boucher J.F., Stegemann M.R. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology 2013, 24. 479-e114.
21. ®) in client-owned dogs with atopic dermatitis. Veterinary Dermatology 2013, 24:587-597. e141; 2.
22. Cosgrove S.B., Cleaver D.M., King V.L., Gilmer A.R., Daniels A.E., Wren J.A., Stegemann M.R. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: Safety, efficacy and quality of life. Veterinary Dermatology 2015, 26:171-179. e35.
23. DeBoer D.J., Griffin C.E. The ACVD task force on canine atopic dermatitis (XXI): Antihistamine pharmacotherapy. Veterinary Immunology and Immunopathology 2001, 81:323-329.
24. DeBoer D.J., Marsella R. The ACVD task force on canine atopic dermatitis (XII): The relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001, 81:239-249.
25. DeBoer D.J., Schafer J.H., Salsbury C.S., Blum J.R., Beale K.M., Vitale C.B., Muse R., Moriello K.A., Garfield R.A., Keefe T.J., et al. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. American Journal of Veterinary Research 2002, 63:408-413.
26. Dell D.L., Griffin C.E., Thompson L.A., Griffies J.D. Owner assessment of therapeutic interventions for canine atopic dermatitis: A long-term retrospective analysis. Veterinary Dermatology 2012, 23. 228-e47.
27. Dip R., Carmichael J., Letellier I., Strehlau G., Roberts E., Bensignor E., Rosenkrantz W. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. BMC Veterinary Research 2013, 9:173.
28. Dodman N.H., Shuster L., Nesbitt G., Weissman A., Lo W.Y., Chang W.W., Cottam N. The use of dextromethorphan to treat repetitive self-directed scratching, biting, or chewing in dogs with allergic dermatitis. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:99-104.
29. Farver K., Morris D.O., Shofer F., Esch B. Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen. Veterinary Dermatology 2005, 16:261-268.
30. Favrot C., Steffan J., Seewald W., Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Veterinary Dermatology 2010, 21:23-31.
31. Fazakerley J., Nuttall T., Sales D., Schmidt V., Carter S.D., Hart C.A., McEwan N.A. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs. Veterinary Dermatology 2009, 20:179-184.
32. Forsythe P., Paterson S. Ciclosporin 10 years on: Indications and efficacy. Veterinary Record 2014, 174(Suppl. 2):13-21.
33. Fujimura M. The study of canine atopic dermatitis involving the isolation of dogs. Polish Journal of Veterinary Sciences 2011, 14:273-277.
34. Fujimura M., Masuda K., Hayashiya M., Okayama T. Flow cytometric analysis of lymphocyte proliferative responses to food allergens in dogs with food allergy. Journal of Veterinary Medical Science 2011, 73:1309-1317.
35. ®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Veterinary Dermatology 2014, 25:512-518. e86.
36. Gonzales A.J., Humphrey W.R., Messamore J.E., Fleck T.J., Fici G.J., Shelly J.A., Teel J.F., Bammert G.F., Dunham S.A., Fuller T.E., et al. Interleukin-31: Its role in canine pruritus and naturally occurring canine atopic dermatitis. Veterinary Dermatology 2013, 24:48-53. e11; 2.
37. ®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Journal of Veterinary Pharmacology and Therapeutics 2014, 37:317-324.
38. Griffin C.E., DeBoer D.J. The ACVD task force on canine atopic dermatitis (XIV): Clinical manifestations of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001, 81:255-269.
39. Griffin C.E., Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): Allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 2001, 81:363-383.
40. Griffin C.E., Rosenkrantz W.S., Thompson P. Prospective survey of reported reactions to allergen-specific immunotherapy injections. Veterinary Dermatology 2014, 25:250.
41. Halliwell R. Revised nomenclature for veterinary allergy. Veterinary Immunology and Immunopathology 2006, 114:207-208.
42. Halliwell R.E.W., Gordon C.M., Horvath C., Wagner R. IgE and IgG antibodies to food antigens in sera from normal dogs, dogs with atopic dermatitis and dogs with adverse food reactions. Advances in Veterinary Dermatology 2005, vol. 5:28-35. Blackwell Publishing, Oxford, UK.
43. Hightower K., Marsella R., Flynn-Lurie A. Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis. Veterinary Dermatology 2010, 21:89-96.
44. Hill P.B., Olivry T. The ACVD task force on canine atopic dermatitis (V): Biology and role of inflammatory cells in cutaneous allergic reactions. Veterinary Immunology and Immunopathology 2001, 81:187-198.
45. Hill P.B., Lo A., Eden C.A., Huntley S., Morey V., Ramsey S., Richardson C., Smith D.J., Sutton C., Taylor M.D., et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Veterinary Record 2006, 158:533-539.
46. Hillier A., Griffin C.E. The ACVD task force on canine atopic dermatitis (I): Incidence and prevalence. Veterinary Immunology and Immunopathology 2001, 81:147-151.
47. Hillier A., Griffin C.E. The ACVD task force on canine atopic dermatitis (X): Is there a relationship between canine atopic dermatitis and cutaneous adverse food reactions?. Veterinary Immunology and Immunopathology 2001, 81:227-231.
48. Hillier A., Moning K.E., Gray L.L. Factors affecting ciclosporin concentrations in canine skin. Veterinary Dermatology 2012, 23(Suppl. 1):63.
49. Hillier A., Lloyd D.H., Weese J.S., Blondeau J.M., Boothe D., Breitschwerd E., Guardabassi L., Papich M.G., Rankin S., Turnidge J.D., et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Veterinary Dermatology 2014, 25:163-175. e42; 3.
50. Horvath-Ungerboeck C., Thoday K.L., Shaw D.J., van den Broek A.H. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: A prospective, randomized, double-blinded, placebo-controlled, cross-over study. Veterinary Dermatology 2009, 20:233-242.
51. Hou C.C., Griffin C.E., Hill P.B. Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines. Veterinary Dermatology 2008, 19:215-220.
52. Inman A.O., Olivry T., Dunston S.M., Monteiro-Riviere N.A., Gatto H. Electron microscopic observations of stratum corneum intercellular lipids in normal and atopic dogs. Veterinary Pathology 2001, 38:720-723.
53. + subset. Veterinary Dermatology 2014, 25:456-e472.
54. Keppel K.E., Campbell K.L., Zuckermann F.A., Greeley E.A., Schaeffer D.J., Husmann R.J. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 2008, 123:337-344.
55. Klukowska-Rötzler J., Chervet L., Müller E.J., Roosje P., Marti E., Janda J. Expression of thymic stromal lymphopoietin in canine atopic dermatitis. Veterinary Dermatology 2013, 24. 54-e14.
56. Kobayashi T., Momoi Y., Iwasaki T. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells. Journal of Veterinary Medical Science 2007, 69:887-892.
57. Lancto C.A., Torres S.M., Hendrickson J.A., Martins K.V., Rutherford M.S. Altered expression of antimicrobial peptide genes in the skin of dogs with atopic dermatitis and other inflammatory skin conditions. Veterinary Dermatology 2013, 24:414-421. e90.
58. Little P.R., King V.L., Davis K.R., Cosgrove S.B., Stegemann M.R. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs. Veterinary Dermatology 2015, 26:23-30. e7; 8.
59. Litzlbauer P., Weber K., Mueller R.S. Recombinant feline interferon-ω as oral or subcutaneous treatment of canine atopic dermatitis. Veterinary Dermatology 2012, 23(Suppl. 1):38.
60. Loflath A., von Voigts-Rhetz A., Jaeger K., Schmidt M., Kuechenhoff H., Mueller R.S. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled study. Veterinary Dermatology 2007, 18:427-431.
61. Lourenco-Martins A.M., Sao-Braz B., Schmidt V.M., Reme C.A., Nuttall T. Long-term maintenance therapy of canine atopic dermatitis with a 0.0584% hydrocortisone aceponate spray (Cortadvance) used on two consecutive days each week. Veterinary Dermatology 2012, 23(Suppl. 1):38.
62. Lourenço-Martins A.M., Delgado E., Neto I., Peleteiro M.C., Morais-Almeida M., Correia J.H. Allergic conjunctivitis and conjunctival provocation tests in atopic dogs. Veterinary Ophthalmology 2011, 14:248-256.
63. Marsella R. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: A pilot study. Veterinary Dermatology 2010, 21:566-571.
64. Marsella R. Atopic disease. Muller & Kirk's Small Animal Dermatology 2013, 365-388. Elsevier Mosby, St. Louis, MO, USA. Seventh Ed. W.H.J. Miller, C.E. Griffin, K.L. Campbell (Eds.).
65. Marsella R. Food hypersensitivity. Muller & Kirk's Small Animal Dermatology 2013, 397-405. Elsevier Mosby, St. Louis, MO, USA. Seventh Ed. W.H.J. Miller, C.E. Griffin, K.L. Campbell (Eds.).
66. Marsella R., Olivry T. The ACVD task force on canine atopic dermatitis (XXII): Nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 2001, 81:331-345.
67. Marsella R., Nicklin C.F., Melloy C. The effects of capsaicin topical therapy in dogs with atopic dermatitis: A randomized, double-blinded, placebo-controlled, cross-over clinical trial. Veterinary Dermatology 2002, 13:131-139.
68. Marsella R., Nicklin C., Lopez J. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Veterinary Dermatology 2006, 17:306-312.
69. Marsella R., Olivry T., Nicklin C.F., Lopez J. Pilot investigation of a model of canine atopic dermatitis: Environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Veterinary Dermatology 2006, 17:24-35.
70. Marsella R., Samuelson D., Doerr K. Transmission electron microscopy studies in an experimental model of canine atopic dermatitis. Veterinary Dermatology 2010, 21:81-88.
71. Marsella R., Olivry T., Carlotti D.N. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Veterinary Dermatology 2011, 22:239-248. for the; International Task Force on Canine Atopic Dermatitis.
72. Marsella R., Genovese D., Gilmer L., Ahrens K. Investigations on the effects of a topical ceramide and free fatty acid solution (Allederm Spot-On) on clinical signs and skin barrier function in dogs with atopic dermatitis: A double-blinded, randomized, controlled study. Veterinary Dermatology 2012, 23(Suppl. 1):66-67.
73. McEwan N.A., Mellor D., Kalna G. Adherence by Staphylococcus intermedius to canine corneocytes: A preliminary study comparing noninflamed and inflamed atopic canine skin. Veterinary Dermatology 2006, 17:151-154.
74. Miller W.H.J., Griffin C.E., Campbell K.L. Muller & Kirk's Small Animal Dermatology 2013, Elsevier Mosby, St. Louis, MO, USA. Seventh Ed.
75. Moriello K.A. Can dextromethorphan be used to treat repetitive itching and scratching in atopic dogs?. Veterinary Medicine 2005, 52:20-23.
76. Morris D.O., Clayton D.J., Drobatz K.J., Felsburg P.J. Response to Malassezia pachydermatis by peripheral blood mononuclear cells from clinically normal and atopic dogs. American Journal of Veterinary Research 2002, 63:358-362.
77. Mueller R.S., Bettenay S.V. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis. American Journal of Veterinary Research 2001, 62:307-310.
78. Mueller R.S., Fieseler K.V., Fettman M.J., Zabel S., Rosychuk R.A., Ogilvie G.K., Greenwalt T.L. Effect of omega-3 fatty acids on canine atopic dermatitis. Journal of Small Animal Practice 2004, 45:293-297.
79. Mueller R.S., Fieseler K.V., Zabel S., Rosychuk R.A.W. Conventional and rush allergen-specific immunotherapy in the treatment of canine atopic dermatitis. Advances in Veterinary Dermatology 2005, vol. 5:60-69. Blackwell Publishing, Oxford, UK.
80. Mueller R.S., Bergvall K., Bensignor E., Bond R. A review of topical therapy for skin infections with bacteria and yeast. Veterinary Dermatology 2012, 23. 330-e62.
81. Negre A., Bensignor E., Guillot J. Evidence-based veterinary dermatology: A systematic review of interventions for Malassezia dermatitis in dogs. Veterinary Dermatology 2009, 20:1-12.
82. Nesbitt G.H., Freeman L.M., Hannah S.S. Correlations of fatty acid supplementation, aeroallergens, shampoo, and ear cleanser with multiple parameters in pruritic dogs. Journal of the American Animal Hospital Association 2004, 40:270-284.
83. Nødtvedt A., Egenvall A., Bergvall K., Hedhammar A. Incidence of and risk factors for atopic dermatitis in a Swedish population of insured dogs. Veterinary Record 2006, 159:241-246.
84. Nuttall T. Update on the immunopathogenesis of canine atopic dermatitis. Proceedings of the Continuing Education Programme of the 7th World Congress of Veterinary Dermatology, Vancouver, Canada 2012, 277-284.
85. Nuttall T., Mueller R., Bensignor E., Verde M., Noli C., Schmidt V., Rème C. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: A randomised, double blind, placebo-controlled trial. Veterinary Dermatology 2009, 20:191-198.
86. Nuttall T., McEwan N.A., Bensignor E., Cornegliani L., Lowerstein C., Reme C.A. Equal efficacy of 0.0548% hydrocortisone aceponate spray and ciclosporin in treating canine atopic dermatitis. Veterinary Dermatology 2010, 21:534.
87. Nuttall T., Reece D., Roberts E. Life-long diseases need life-long treatment: Long-term safety of ciclosporin in canine atopic dermatitis. Veterinary Record 2014, 174(Suppl. 2):3-12.
88. Nuttall T.J., Halliwell R.E. Serum antibodies to Malassezia yeasts in canine atopic dermatitis. Veterinary Dermatology 2001, 12:327-332.
89. Nuttall T.J., Knight P.A., McAleese S.M., Lamb J.R., Hill P.B. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Veterinary Immunology and Immunopathology 2002, 87:379-384.
90. Nuttall T.J., Knight P.A., McAleese S.M., Brown J., Lamb J.R., Hill P.B. Expression of Th1-cytokine mRNA in canine atopic dermatitis correlates with severity of clinical lesions. Advances in Veterinary Dermatology 2005, vol. 5:17-27. Blackwell Publishing, Oxford, UK.
91. Nuttall T.J., McEwan N.A., Bensignor E., Cornegliani L., Löwenstein C., Rème C.A. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Veterinary Dermatology 2012, 23:4-10. e1; 2.
92. Ohmori K., Tanaka A., Makita Y., Takai M., Yoshinari Y., Matsuda H. Pilot evaluation of the efficacy of shampoo treatment with ultrapure soft water for canine pruritus. Veterinary Dermatology 2010, 21:477-483.
93. Oldenhoff W.E., Frank G.R., DeBoer D.J. Comparison of the results of intradermal test reactivity and serum allergen-specific IgE measurement for Malassezia pachydermatis in atopic dogs. Veterinary Dermatology 2014, 25:507-511. e84; 5.
94. Olivry T., Bizikova P. A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Veterinary Dermatology 2013, 24. 97-e26.
95. Olivry T., Dunston S.M. Expression patterns of superficial epidermal adhesion molecules in an experimental dog model of acute atopic dermatitis skin lesions. Veterinary Dermatology 2015, 26:53-56. e-17; 8.
96. Olivry T., Hill P.B. The ACVD task force on canine atopic dermatitis (IX): The controversy surrounding the route of allergen challenge in canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001, 81:219-225.
97. Olivry T., Sousa C.A. The ACVD task force on canine atopic dermatitis (XIX): General principles of therapy. Veterinary Immunology and Immunopathology 2001, 81:311-316.
98. Olivry T., Sousa C.A. The ACVD task force on canine atopic dermatitis (XX): Glucocorticoid pharmacotherapy. Veterinary Immunology and Immunopathology 2001, 81:317-322.
99. Olivry T., Naydan D.K., Moore P.F. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. The American Journal of Dermatopathology 1997, 19:477-486.
100. Olivry T., Marsella R., Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): Are essential fatty acids effective?. Veterinary Immunology and Immunopathology 2001, 81:347-362.
101. Olivry T., Steffan J., Fisch R.D., Prélaud P., Guaguère E., Fontaine J., Carlotti D.N. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 2002, 221:370-377. European Veterinary Dermatology Ciclosporin Group.
102. Olivry T., Dunston S.M., Rivierre C., Jackson H.A., Murphy K.M., Peters E., Dean G.A. A randomized controlled trial of misoprostol monotherapy for canine atopic dermatitis: Effects on dermal cellularity and cutaneous tumour necrosis factor-alpha. Veterinary Dermatology 2003, 14:37-46.
103. Olivry T., Mueller R.S. Evidence-based veterinary dermatology: A systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003, 14:121-146. International Task Force on Canine Atopic Dermatitis.
104. Olivry T., DeBoer D.J., Prelaud P., Bensignor E. Food for thought: Pondering the relationship between canine atopic dermatitis and cutaneous adverse food reactions. Veterinary Dermatology 2007, 18:390-391.
105. Olivry T., DeBoer D.J., Favrot C., Jackson H.A., Mueller R.S., Nuttall T., Prélaud P. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology 2010, 21:233-248. for the; International Task Force on Canine Atopic Dermatitis.
106. Olivry T., Foster A.P., Mueller R.S., McEwan N.A., Chesney C., Williams H.C. Interventions for atopic dermatitis in dogs: A systematic review of randomized controlled trials. Veterinary Dermatology 2010, 21:4-22.
107. Olivry T., Wofford J., Paps J.S., Dunston S.M. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs. Veterinary Dermatology 2011, 22:188-196.
108. Palmeiro B.S. Cyclosporine in veterinary dermatology. Veterinary Clinics of North America-Small Animal Practice 2013, 43:153-171.
109. Park S.J., Ohya F., Yamashita K., Nishifuji K., Iwasaki T. Comparison of response to immunotherapy by intradermal skin test and antigen-specific IgE in canine atopy. Journal of Veterinary Medical Science 2000, 62:983-988.
110. Picco F., Zini E., Nett C., Naegeli C., Bigler B., Rüfenacht S., Roosje P., Gutzwiller M.E., Wilhelm S., Pfister J., et al. A prospective study on canine atopic dermatitis and food-induced allergic dermatitis in Switzerland. Veterinary Dermatology 2008, 19:150-155.
111. Piekutowska A., Pin D., Rème C.A., Gatto H., Haftek M. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. Journal of Comparative Pathology 2008, 138:197-203.
112. Popa I., Pin D., Remoué N., Osta B., Callejon S., Videmont E., Gatto H., Portoukalian J., Haftek M. Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed supplement. A pilot study. Veterinary Research Communications 2011, 35:501-509.
113. Proverbio D., Perego R., Spada E., Ferro E. Prevalence of adverse food reactions in 130 dogs in Italy with dermatological signs: A retrospective study. Journal of Small Animal Practice 2010, 51:370-374.
114. Pucheu-Haston C.M., Shuster D., Olivry T., Brianceau P., Lockwood P., McClanahan T., Malefyt R.W., Mattson J.D., Hammemberg B. A canine model of cutaneous late-phase reactions: Prednisolone inhibition of cellular and cytokine responses. Immunology 2005, 117:177-187.
115. Pucheu-Haston C.M., Jackson H.A., Olivry T., Dunston S.M., Hammerberg B. Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis. Clinical and Experimental Allergy 2008, 38:667-679.
116. Puigdemont A., Brazís P., Ordeix L., Dalmau A., Fuertes E., Olivar A., Pérez C., Ravera I. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs. The Veterinary Journal 2013, 197:280-285.
117. Rosser E.J.J. Comparison of intradermal testing and allergen-specific IgE serum testing in dogs with warm weather, seasonal atopic dermatitis. Advances in Veterinary Dermatology 2005, vol. 5:42-48. Blackwell Publishing, Oxford, UK.
118. Rostaher Prélaud A., Fuchs S., Weber K., Winter G., Coester C., Mueller R.S. In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs-a pilot study. Veterinary Dermatology 2013, 24. 494-e117.
119. Saevik B.K., Thoresen S.I., Kristensen F. A retrospective study of hyposensitization in canine atopy based on a polyclonal ELISA test. Veterinary Research Communications 2002, 26:613-624.
120. Saevik B.K., Bergvall K., Holm B.R., Saijonmaa-Koulumies L.E., Hedhammar A., Larsen S., Kristensen F. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology 2004, 15:137-145.
121. Santoro D., Bunick D., Graves T.K., Segre M. Evaluation of canine antimicrobial peptides in infected and noninfected chronic atopic skin. Veterinary Dermatology 2013, 24:39-47. e10.
122. Santoro D., Marsella R., Ahrens K., Graves T.K., Bunick D. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis. Veterinary Dermatology 2013, 24:329-336. e73.
123. Saridomichelakis M.N., Koutinas A.F. Cutaneous involvement in canine leishmaniosis due to Leishmania infantum (syn. L. chagasi). Veterinary Dermatology 2014, 25:61-71. e22.
124. Saridomichelakis M.N., Farmaki R., Leontides L.S., Koutinas A.F. Aetiology of canine otitis externa: A retrospective study of 100 cases. Veterinary Dermatology 2007, 18:341-347.
125. Schamber P., Schwab-Richards R., Bauersachs S., Mueller R.S. Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinae. G3 (Bethesda) 2014, 4:1787-1795.
126. Schnabl B., Bettenay S.V., Dow K., Mueller R.S. Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis. Veterinary Record 2006, 158:81-85.
127. Scott D.W., Miller W.H., Griffin C.E. Canine atopic disease. Muller & Kirk's Small Animal Dermatology 2001, 574-601. W.B. Saunders, Philadelphia, PA, USA. Sixth Ed.
128. Shida M., Kadoya M., Park S.J., Nishifuji K., Momoi Y., Iwasaki T. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis. Veterinary Immunology and Immunopathology 2004, 102:19-31.
129. Shimada K., Yoon J.S., Yoshihara T., Iwasaki T., Nishifuji K. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis. Veterinary Dermatology 2009, 20:541-546.
130. Simou C., Thoday K.L., Forsythe P.J., Hill P.B. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: Effect of pyoderma, pruritus score, treatment and gender. Veterinary Dermatology 2005, 16:385-391.
131. Singh S.K., Dimri U., Saxena S.K., Jadhav R.K. Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs. Journal of Veterinary Pharmacology and Therapeutics 2010, 33:495-498.
132. Sousa C.A., Halliwell R.E. The ACVD task force on canine atopic dermatitis (XI): The relationship between arthropod hypersensitivity and atopic dermatitis in the dog. Veterinary Immunology and Immunopathology 2001, 81:233-237.
133. Stahl J., Paps J., Bäumer W., Olivry T. Dermatophagoides farinae house dust mite allergen challenges reduce stratum corneum ceramides in an experimental dog model of acute atopic dermatitis. Veterinary Dermatology 2012, 23. 497-e97.
134. Steffan J., Alexander D., Brovedani F., Fisch R.D. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: A parallel, blinded, randomized controlled trial. Veterinary Dermatology 2003, 14:11-22.
135. Steffan J., Favrot C., Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 2006, 17:3-16.
136. Stehle M.E., Hanczaruk M., Schwarz S.C., Göbel T.W., Mueller R.S. Effects of polyunsaturated fatty acids on isolated canine peripheral blood mononuclear cells and cytokine expression (IL-4, IFN-gamma, TGF-beta) in healthy and atopic dogs. Veterinary Dermatology 2010, 21:112-117.
137. Swinnen C., Vroom M. The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs. Veterinary Dermatology 2004, 15:31-36.
138. Tarpataki N., Papa K., Reiczigel J., Vajdovich P., Voros K. Prevalence and features of canine atopic dermatitis in Hungary. Acta Veterinaria Hungarica 2006, 54:353-366.
139. Theerawatanasirikul S., Sailasuta A., Thanawongnuwech R., Suriyaphol G. Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis. Research in Veterinary Science 2012, 93:1287-1292.
140. Torres S.M., Diaz S.F., Nogueira S.A., Jessen C., Polzin D.J., Gilbert S.M., Horne K.L. Frequency of urinary tract infection among dogs with pruritic disorders receiving long-term glucocorticoid treatment. Journal of the American Veterinary Medical Association 2005, 227:239-243.
141. van Damme C.M., Willemse T., van Dijk A., Haagsman H.P., Veldhuizen E.J. Altered cutaneous expression of beta-defensins in dogs with atopic dermatitis. Molecular Immunology 2009, 46:2449-2455.
142. Virga V. Behavioral dermatology. Veterinary Clinics of North America-Small Animal Practice 2003, 33:231-251.
143. Willemse A., Van den Brom W.E., Rijnberk A. Effect of hyposensitization on atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 1984, 184:1277-1280.
144. Zur G., Ihrke P.J., White S.D., Kass P.H. Canine atopic dermatitis: A retrospective study of 266 cases examined at the University of California, Davies, 1992-1998. Part I. Clinical features and allergy testing results. Veterinary Dermatology 2002, 13:89-102.
145. Zur G., White S.D., Ihrke P.J., Kass P.H., Toebe N. Canine atopic dermatitis: A retrospective study of 169 cases examined at University of California, Davis, 1992-1998. Part II. Response to hyposensitization. Veterinary Dermatology 2002, 13:103-111.